CircRBM33 may combine with DNMT1, and regulate the resistance of H1975 osimertinib-resistant cells to osimertinib that mediated by IL6.
CircRBM33 promotes migration, invasion and mediates osimertinib resistance in non-small cell lung cancer cell line.